Table 1.
Demographic and clinical data of patients with COVID-19
| Total (n = 115) |
S. pneumonia positive (n = 37) | S. pneumonia negative (n = 78) | p value | |
|---|---|---|---|---|
| Age, years (median, min-max) | 9 (3–14) | 4 (1–11) | 10 (4–14) | 0.009 |
| Male (%) | 61 (50.8) | 20 (52.6) | 41 (50) | 0.59 |
| Rate of Refugees, n (%) | 31 (26.9) | 12 (32.4) | 19 (24.4) | 0.36 |
| Underlying disease, n (%) | 9 (7.5) | 2 (5.3) | 7 (8.5) | 0.71 |
| Symptoms, n (%) | ||||
| Fever | 43 (35.8) | 15 (39.5) | 28 (34.1) | 0.63 |
| Cough | 43 (35.8) | 15 (39.1) | 28 (34.1) | 0.63 |
| Laboratory findings, n (%) | ||||
| Leukocytosis | 0 | 0 | 0 | NA |
| Lymphopenia | 24 (20) | 5 (13.2) | 19 (23.2) | 0.18 |
| Increased CRP | 28/88 (31.8) | 5/32 (15.6) | 12/70 (17.1) | 0.84 |
| Increased Procalcitonin | 0/77 (0) | 0/24 (0) | 0/53 (0) | NA |
| Increased LDH | 28/88 (31.8) | 13/26 (50) | 15/62 (24.2) | 0.03 |
| D dimer | 7/25 (28) | 4/10 (40) | 3/15 (20) | 0.37 |
| Chest x-ray, n (%) | 120 (100) | |||
| Abnormal | 38 (31.7) | 11 (28.9) | 27 (32.9) | 0.60 |
| Thorax CT, n (%) | 30 (40) | |||
| Normal | 19/30 (15.8) | 8/11 (72.7) | 11/19 (57.8) | 0.46 |
| Abnormal | 11/30 (9.2) | 3/11 (27.2) | 8/19 (42.1) | |
| Severity | ||||
| Asymptomatic | 32 (26.7) | 10 (26.3) | 22 (26.3) | NA |
| Mild | 51 (42.5) | 16 (42.1) | 31 (42.7) | |
| Moderate | 34 (28.3) | 11 (28.9) | 18 (28) | |
| Severe/Critical | 3 (2.5) | 1 (2.6) | 2 (2.4) | |
| Antibacterial treatment, n (%) | 23 (20) | 7 (18.9) | 16 (20.5) | 0.76 |
| Antiviral treatment, n (%) | 2 (1.7) | 1 (2.7) | 2 (1.3) | NA |
CRP; C-reactive protein, LDH; Lactate dehydrogenase, CT; Computer tomography,